Sunlight Solutions Announces the Launch of AI Assist
16 avr. 2024 11h15 HE
|
Sunlight Solutions
Sunlight Solutions is pleased to announce the deployment of AI Assist, a toolkit that connects modern AI technologies to key insurance use cases.
Sunlight Solutions Announces 2023 Results
12 déc. 2023 14h51 HE
|
Sunlight Solutions
Sunlight Solutions is pleased to announce the company’s year-to-date (YTD) actual performance has eclipsed all projections for 2023.
New York State Approves Precipio’s HemeScreen for POL clinical use
18 nov. 2021 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from...
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory
26 août 2021 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn. and FORT MYERS, Fla., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), and American Oncology Network, LLC (AON), a high-growth...
Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups
20 janv. 2021 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has signed agreements with two of the largest oncology practices in the US,...
Precipio Adds Another HemeScreen™ Customer
09 juin 2020 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., June 09, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that Cancer and Hematology Centers of Western Michigan (CHCWM) has adopted...
Precipio Launches New HemeScreen™ Reagent Rental Program
06 avr. 2020 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 06, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched its HemeScreen™ Reagent Rental (HSRR) program....
First Substantial Customer: Tennessee Oncology Internalizes Precipio’s HemeScreen™
30 sept. 2019 11h10 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that Tennessee Oncology has selected Precipio’s HemeScreen RUO assay as...
Precipio’s HemeScreen™ Adopted by Methodist Health
03 avr. 2019 07h38 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 03, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that Methodist Hospital, located in Memphis, TN, has selected...